IPO7 anticorps (AA 50-100)
Aperçu rapide pour IPO7 anticorps (AA 50-100) (ABIN1905570)
Antigène
Voir toutes IPO7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 50-100
-
Specificité
- Region between residue 50 and 100 of human Importin 7 using the numbering given in entry NP_006382.1 (GeneID 10527).
-
Purification
- Affinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:100 - 1:1000), IHC, IHC-P (1:200 - 1:1000), IP (5 - 15 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Ovarian Carcinoma. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- IPO7 (Importin 7 (IPO7))
-
Autre désignation
- IPO7 / RANBP7
-
Sujet
-
Name/Gene ID: IPO7
Synonyms: IPO7, Importin-7, Importin 7, Ran-binding protein 7, Imp7, RAN binding protein 7, RanBP7 -
ID gène
- 10527
-
Pathways
- Protein targeting to Nucleus
Antigène
-